[1] |
Choi HK,Mount DB,Reginato AM.Pathogenesis of gout[J]. Ann Intern Med,2005, 143(7):499-516.
|
[2] |
Yuan JL,Peng MX,Sun M,et al.Current study of gout pathogenesis and medication [J]. Chin Pharm Aff(中国药事),2014, 28(1):86-90.
|
[3] |
Navolanic PM,Pui CH,Larson RA,et al.ElitekTM-rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome[J]. Leukemia,2003, 17(3):499-514.
|
[4] |
Burns CM,Wortmann RL.Gout therapeutics:new drugs for an old disease [J]. Lancet,2011, 377(9760):165-177.
|
[5] |
Becker MA,Kisicki J,Khosravan R,et al.Febuxostat(TMX-67),a novel,non-purine,selective inhibitor of xanthine oxidase,is safe and decreases serum urate in healthy volunteers[J]. Nucleos Nucleoti Nucl,2004, 23(8/9):1111-1116.
|
[6] |
Naumova AV,Chacko VP,Ouwerkerk R,et al.Xanthine oxidase inhibitors improve energetics and function following infarction in the failing mouse heart[J]. Am J Physiol Heart Circ Physiol,2006, 290(2):837-843.
|
[7] |
Gerhard O, Biberach R. Novel 5H-dihydrothiopyran[4,3-d]pyrimidines:US,3316257[P].1967-03-25[2014-12-26] .
|
[8] |
Takano Y,Hase-Aoki K,Horiuchi H,et al.Selectivity of febuxostat,a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase[J]. Life Sci,2005, 76(16):1835-1847.
|
[9] |
Rule NG,Detty MR,Keading JE,et al.Syntheses of 4H-thiopyran-4-one 1,1-dioxides as precursors to sulfone-containing analogues of tetracyanoquinodimethane[J]. J Org Chem,1995, 60(6):1665-1673.
|
[10] |
Zhu SY,Zhou YD,Liu QS,et al.Establishment and application of a high-throughput screening assay for xanthine oxidase inhibitor in vitro [J]. Chin Pharm J(中国药学杂志),2007, 42(3):187-190.
|
[11] |
Li Y,Chen J,Li P.Inhibitory activity of the flavonoids and phenolic acids from Jinyinhua on the xanthine oxidase [J]. J China Pharm Univ(中国药科大学学报),2011, 42(5):407-411.
|
[12] |
Nguyen MT,Awale S,Tezuka Y,et al.Xanthine oxidase inhibitors from the flowers of Chrysanthemum sinense[J]. Planta Med,2006, 72(1):46-51.
|
[13] |
Hsieh JF,Wu SH,Yang YL,et al.The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors[J]. Bioorg Med Chem,2007, 15(10):3450-3456.
|